Presbyopia Eye Drops in the UK: The Complete Guide (2026)

Every week, thousands of people in the UK search for answers about presbyopia eye drops. They type questions like "can you buy VIZZ in the UK?", "when will Vuity be available here?" or "are there eye drops that fix reading vision?" into Google and into AI assistants like ChatGPT. This guide pulls every answer into one place, so you do not have to piece it together from scattered sources.

What are presbyopia eye drops?

Presbyopia eye drops are prescription drops that temporarily restore near vision in people aged roughly 40 to 65. Presbyopia is the age-related stiffening of the eye's lens, which makes reading text up close difficult without glasses. The drops use a small dose of an active ingredient that shrinks the pupil slightly, increasing the eye's depth of focus so near text becomes readable again for several hours.

Three brands are approved and selling in the United States: VIZZ (the brand name for aceclidine), Vuity and Qlosi. They are not yet approved in the UK or Europe. UK approval is expected around early 2027.

Can you buy VIZZ eye drops in the UK?

Not yet. VIZZ, which uses the active ingredient aceclidine, is approved in the USA but has not completed UK regulatory review. Anyone selling VIZZ in the UK today would be doing so outside the law, and any site claiming to ship it here should be treated with caution. The legitimate route is to wait for UK approval, then obtain the drops through a regulated prescription from a UK-registered prescriber.

Vision Drops UK exists precisely for this gap: we are building a free waitlist so that, at launch, people on the list can move straight into a regulated online clinical assessment and be among the first in the country to receive the drops.

When will presbyopia eye drops be approved in the UK?

Current expectation is early 2027, subject to regulatory review. Approval in the UK typically follows some years behind the US as manufacturers complete the required dossiers for UK and European regulators. Once approved, drops will be prescription-only: you will need an assessment by a UK-regulated prescriber before you can receive them.

What about Vuity and Qlosi in the UK?

Same situation. Vuity (pilocarpine 1.25%) and Qlosi (pilocarpine 0.4%) are US-approved prescription drops for presbyopia. Neither is approved for sale in the UK yet. All three brands work on the same principle: a mild pupil-constricting effect that sharpens near vision for roughly four to six hours per drop.

Do presbyopia eye drops actually work?

In US clinical trials, a meaningful majority of participants could read several additional lines on a near-vision chart within 30 minutes of a drop, without losing distance vision. Effects vary by person and by day. Common side effects are mild and temporary: slight headache, eye redness or a dimmer feeling in low light. The drops do not cure presbyopia; they buy you glasses-free hours while they are active.

Are presbyopia eye drops available on the NHS?

Not currently, and NHS funding at launch is unlikely in the first instance. New treatments for quality-of-life conditions typically launch privately first, with any NHS consideration coming years later. The practical expectation for UK patients is a private prescription, purchased online through a regulated dispensing pharmacy partner and delivered to your door.

What is the best alternative to reading glasses right now?

Today, your options are reading glasses, multifocal contact lenses, monovision contacts, or surgical options such as lens replacement. Until drops are approved in the UK, glasses and contacts remain the only safe choices, which is why keeping your eye test up to date matters. A valid, recent eye test report from a high-street optician will also be needed before any future prescriber can sign off drops for you.

How do I get priority access when drops launch in the UK?

• Join the free Vision Drops UK waitlist: it takes under a minute and captures your age band and a short presbyopia pre-screening.
• Book a current eye test with a UK optician now: a report issued within the last 12 months will be required at launch.
• Watch for the approval announcement: everyone on the waitlist will be contacted first with a private clinical intake link.
• Complete the online assessment: a real UK-regulated prescriber reviews it before anything is dispensed.